Liminatus Pharma, Inc. (LIMN)
0.2028
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
0.201
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Market Cap : 9.101M for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oruka Therapeutics, Inc. | 3.200B |
| MapLight Therapeutics, Inc. | 1.163B |
| Kailera Therapeutics, Inc. | 2.781B |
| Veracyte, Inc. | 3.225B |
| Insight Molecular Diagnostics, Inc. | 161.16M |
Market Cap Related Metrics
| PEG Ratio | -0.0017 |
| Price | 0.2028 |
| Earnings Yield | -179.7% |
| PEGY Ratio | -0.0017 |